Cargando…

Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment

BACKGROUND: Onchocerca volvulus is the causative agent of onchocerciasis, or “river blindness”. Ivermectin has been used for mass treatment of onchocerciasis for up to 18 years, and recently there have been reports of poor parasitological responses to the drug. Should ivermectin resistance be develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourguinat, Catherine, Pion, Sébastien D. S., Kamgno, Joseph, Gardon, Jacques, Duke, Brian O. L., Boussinesq, Michel, Prichard, Roger K.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2041821/
https://www.ncbi.nlm.nih.gov/pubmed/17989786
http://dx.doi.org/10.1371/journal.pntd.0000072
_version_ 1782137095318405120
author Bourguinat, Catherine
Pion, Sébastien D. S.
Kamgno, Joseph
Gardon, Jacques
Duke, Brian O. L.
Boussinesq, Michel
Prichard, Roger K.
author_facet Bourguinat, Catherine
Pion, Sébastien D. S.
Kamgno, Joseph
Gardon, Jacques
Duke, Brian O. L.
Boussinesq, Michel
Prichard, Roger K.
author_sort Bourguinat, Catherine
collection PubMed
description BACKGROUND: Onchocerca volvulus is the causative agent of onchocerciasis, or “river blindness”. Ivermectin has been used for mass treatment of onchocerciasis for up to 18 years, and recently there have been reports of poor parasitological responses to the drug. Should ivermectin resistance be developing, it would have a genetic basis. We monitored genetic changes in parasites obtained from the same patients before use of ivermectin and following different levels of ivermectin exposure. METHODS AND FINDINGS: O. volvulus adult worms were obtained from 73 patients before exposure to ivermectin and in the same patients following three years of annual or three-monthly treatment at 150 µg/kg or 800 µg/kg. Genotype frequencies were determined in β-tubulin, a gene previously found to be linked to ivermectin selection and resistance in parasitic nematodes. Such frequencies were also determined in two other genes, heat shock protein 60 and acidic ribosomal protein, not known to be linked to ivermectin effects. In addition, we investigated the relationship between β-tubulin genotype and female parasite fertility. We found a significant selection for β-tubulin heterozygotes in female worms. There was no significant selection for the two other genes. Quarterly ivermectin treatment over three years reduced the frequency of the β-tubulin “aa” homozygotes from 68.6% to 25.6%, while the “ab” heterozygotes increased from 20.9% to 69.2% in the female parasites. The female worms that were homozygous at the β-tubulin locus were more fertile than the heterozygous female worms before treatment (67% versus 37%; p = 0.003) and twelve months after the last dose of ivermectin in the groups treated annually (60% versus 17%; p<0.001). Differences in fertility between heterozygous and homozygous worms were less apparent three months after the last treatment in the groups treated three-monthly. CONCLUSIONS: The results indicate that ivermectin is causing genetic selection on O. volvulus. This genetic selection is associated with a lower reproductive rate in the female parasites. We hypothesize that this genetic selection indicates that a population of O. volvulus, which is more tolerant to ivermectin, is being selected. This selection could have implications for the development of ivermectin resistance in O. volvulus and for the ongoing onchocerciasis control programmes.
format Text
id pubmed-2041821
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-20418212007-11-07 Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment Bourguinat, Catherine Pion, Sébastien D. S. Kamgno, Joseph Gardon, Jacques Duke, Brian O. L. Boussinesq, Michel Prichard, Roger K. PLoS Negl Trop Dis Research Article BACKGROUND: Onchocerca volvulus is the causative agent of onchocerciasis, or “river blindness”. Ivermectin has been used for mass treatment of onchocerciasis for up to 18 years, and recently there have been reports of poor parasitological responses to the drug. Should ivermectin resistance be developing, it would have a genetic basis. We monitored genetic changes in parasites obtained from the same patients before use of ivermectin and following different levels of ivermectin exposure. METHODS AND FINDINGS: O. volvulus adult worms were obtained from 73 patients before exposure to ivermectin and in the same patients following three years of annual or three-monthly treatment at 150 µg/kg or 800 µg/kg. Genotype frequencies were determined in β-tubulin, a gene previously found to be linked to ivermectin selection and resistance in parasitic nematodes. Such frequencies were also determined in two other genes, heat shock protein 60 and acidic ribosomal protein, not known to be linked to ivermectin effects. In addition, we investigated the relationship between β-tubulin genotype and female parasite fertility. We found a significant selection for β-tubulin heterozygotes in female worms. There was no significant selection for the two other genes. Quarterly ivermectin treatment over three years reduced the frequency of the β-tubulin “aa” homozygotes from 68.6% to 25.6%, while the “ab” heterozygotes increased from 20.9% to 69.2% in the female parasites. The female worms that were homozygous at the β-tubulin locus were more fertile than the heterozygous female worms before treatment (67% versus 37%; p = 0.003) and twelve months after the last dose of ivermectin in the groups treated annually (60% versus 17%; p<0.001). Differences in fertility between heterozygous and homozygous worms were less apparent three months after the last treatment in the groups treated three-monthly. CONCLUSIONS: The results indicate that ivermectin is causing genetic selection on O. volvulus. This genetic selection is associated with a lower reproductive rate in the female parasites. We hypothesize that this genetic selection indicates that a population of O. volvulus, which is more tolerant to ivermectin, is being selected. This selection could have implications for the development of ivermectin resistance in O. volvulus and for the ongoing onchocerciasis control programmes. Public Library of Science 2007-08-30 /pmc/articles/PMC2041821/ /pubmed/17989786 http://dx.doi.org/10.1371/journal.pntd.0000072 Text en Bourguinat et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Bourguinat, Catherine
Pion, Sébastien D. S.
Kamgno, Joseph
Gardon, Jacques
Duke, Brian O. L.
Boussinesq, Michel
Prichard, Roger K.
Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment
title Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment
title_full Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment
title_fullStr Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment
title_full_unstemmed Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment
title_short Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment
title_sort genetic selection of low fertile onchocerca volvulus by ivermectin treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2041821/
https://www.ncbi.nlm.nih.gov/pubmed/17989786
http://dx.doi.org/10.1371/journal.pntd.0000072
work_keys_str_mv AT bourguinatcatherine geneticselectionoflowfertileonchocercavolvulusbyivermectintreatment
AT pionsebastiends geneticselectionoflowfertileonchocercavolvulusbyivermectintreatment
AT kamgnojoseph geneticselectionoflowfertileonchocercavolvulusbyivermectintreatment
AT gardonjacques geneticselectionoflowfertileonchocercavolvulusbyivermectintreatment
AT dukebrianol geneticselectionoflowfertileonchocercavolvulusbyivermectintreatment
AT boussinesqmichel geneticselectionoflowfertileonchocercavolvulusbyivermectintreatment
AT prichardrogerk geneticselectionoflowfertileonchocercavolvulusbyivermectintreatment